• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, November 19, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Sinusoidal Trifocal Intraocular Lenses Improve Intermediate and Near Visual Acuity

by
November 11, 2026
in Health
Reading Time: 7 mins read
0
Sinusoidal Trifocal Intraocular Lenses Improve Intermediate and Near Visual Acuity

Sinusoidal Trifocal Intraocular Lenses Improve Intermediate and Near Visual Acuity

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

In a retrospective comparative cohort study tracking 340 patients undergoing bilateral cataract surgery and intraocular lens implantation, researchers found that a sinusoidal pupil-adaptive trifocal intraocular lens yielded superior uncorrected intermediate and near visual acuity at 12 months compared with a conventional diffractive trifocal design. The investigation, conducted at the Department of Ophthalmology within the University of Health Sciences Prof. Dr. Cemil Taşcıoğlu City Hospital in Istanbul, Türkiye, evaluated consecutive routine-care patients operated on between 1 June 2022 and 1 June 2024. While both surgical implants achieved excellent uncorrected distance acuity and comparable refractive accuracy, the functional separation between the optical architectures became apparent across intermediate working distances of 65 centimetres and near tasks at 40 centimetres. Because presbyopia-correcting intraocular lenses aim to minimize spectacle dependence across varied daily activities, understanding how distinct physical designs apportion incident light across designated focal points represents a critical consideration in modern ophthalmic care.

Trifocal optical platforms generally seek to distribute light across distance, intermediate, and near foci to alleviate patient reliance on reading glasses while preserving functional clarity. However, the physical architecture through which an optical lens separates incoming light rays governs its through-focus profile, contrast preservation, and the manifestation of visual photic symptoms such as halos or glare. In the published literature, comparative evaluations have often been restricted to narrow assessment batteries consisting solely of fixed-distance visual acuity, frequently omitting concurrent defocus curves, contrast sensitivity measurements under challenging lighting, or standardized patient-reported function. Furthermore, published clinical cohorts addressing advanced multifocal profiles typically feature sample sizes below one hundred eyes per study arm, constraining the precision of comparisons regarding optical aberrations, subjective visual quality, and complete spectacle freedom. For sinusoidal, pupil-adaptive optics in particular, independent peer-reviewed clinical data had previously been limited to a single series reporting 6-month surgical outcomes.

To evaluate these two contrasting approaches to multifocal light distribution in a broader routine-care population, the investigators established a comprehensive assessment battery applied identically across two distinct cohorts. The clinical protocol compared the AcrivaUD Trinova Pro C, manufactured by VSY Biotechnology GmbH, against the Omni Trioptix Trifocal, produced by Omni Lens Pvt. Ltd. The Trinova platform incorporates a sinusoidal, pupil-adaptive optical profile providing additions of +1.80 dioptres for intermediate vision and +3.60 dioptres for near vision at the lens plane. In contrast, the Omni Trioptix platform relies on a conventional diffractive optical surface providing +1.75 dioptres of intermediate power and +3.50 dioptres of near power. Both devices held commercial availability and regulatory approvals, including the CE mark for the sinusoidal platform, but their comparative functional performance across twelve full months of clinical recovery had not been evaluated within a single concurrent cohort.

The cohort selection process began by screening 432 consecutive clinical records of patients who received bilateral implants of either lens model during the defined two-year surgical window. To eliminate inter-eye correlation while maintaining methodological independence, the analysis designated exactly one right eye from each eligible participant prior to any inspection of clinical outcomes, with the fellow eye explicitly barred from substitution. Strict anatomical and clinical exclusion criteria removed 92 individuals from the initial candidate pool: 36 patients lacked an eligible right study eye due to unilateral procedures or fellow-eye mismatches, 31 did not complete full 12-month follow-up examinations, 17 presented ocular comorbidities or perioperative complications capable of confounding visual acuity, and eight lacked complete outcome data records. The excluded medical conditions spanned intraoperative complications, significant corneal opacity or irregular astigmatism, advanced glaucoma, macular disease, neuro-ophthalmic disorders, amblyopia, prior refractive interventions, posterior capsule rupture, and postoperative cystoid macular oedema, yielding exactly 170 qualified right eyes in each study arm.

Surgical execution remained uniform throughout the series, with all 340 operations performed by a single surgeon utilizing clear-corneal phacoemulsification, continuous curvilinear capsulorhexis, and in-the-bag intraocular lens placement. Lens power calculations relied on the Barrett Universal II formula using manufacturer-recommended A-constants—specifically 118.0 for the sinusoidal platform and 118.4 for the diffractive comparator—aiming for postoperative emmetropia in every case without post-hoc mathematical constant adjustments. Preoperative evaluations established manifest refraction, corrected distance visual acuity, intraocular pressure, optical biometry, and pupil diameter under photopic and mesopic illumination. Following surgery, patients observed standard institutional topical antibiotic and corticosteroid drop regimens. Allocation between the two lens types was non-randomized, reflecting routine hospital supply availability, surgeon choice, and patient characteristics across three consecutive operative intervals, which introduced measurable baseline imbalances in preoperative visual acuity, corneal keratometry, and demographic distributions.

The study designated two primary clinical endpoints selected a priori prior to database access and comparative statistical analysis: uncorrected intermediate visual acuity tested at 65 centimetres and uncorrected near visual acuity measured at 40 centimetres, both recorded at the 12-month postoperative milestone. Secondary outcomes tracked distance acuity, manifest refraction spherical equivalent, predictability within ±0.50 and ±1.00 dioptres of target, monocular defocus curves from +1.00 to −4.00 dioptres in half-dioptre increments, and contrast sensitivity across spatial frequencies of 3, 6, 12, and 18 cycles per degree using the CSV-1000E under photopic glare-free and mesopic glare conditions. Patient-reported measures incorporated the validated Turkish translation of the 25-item National Eye Institute Visual Function Questionnaire, numeric symptom ratings from 0 to 10 for glare, halos, and night-driving difficulty, categorical spectacle independence across specific distances, and patient willingness to undergo identical lens selection again.

Twelve months after lens implantation, uncorrected visual acuity testing revealed statistically significant functional advantages for the sinusoidal optical design across both designated primary working distances. Intermediate acuity measured 0.09 logMAR (standard deviation 0.05) in the sinusoidal group compared with 0.12 logMAR (standard deviation 0.05) in the diffractive group, yielding an adjusted multivariable difference of −0.025 logMAR (95% confidence interval −0.037 to −0.013; P < 0.001). Near visual performance demonstrated a wider separation, recording 0.10 logMAR (standard deviation 0.06) for sinusoidal recipients versus 0.16 logMAR (standard deviation 0.05) among diffractive recipients, corresponding to an adjusted difference of −0.066 logMAR (95% confidence interval −0.080 to −0.053; P < 0.001). Intermediate and near visual advantages had already manifested at 3 months postoperatively, maintaining identical directional separation throughout extended convalescence. Distance acuity differences, while reaching numerical significance at 12 months, remained at or below a single chart letter, indicating clinically equivalent distance performance.

Refractive accuracy proved highly consistent between both intraocular platforms, confirming the predictability of optical biometry formulas across distinct manufactured materials. At 12 months, the manifest refraction spherical equivalent averaged −0.21 dioptres (standard deviation 0.32) in the sinusoidal group and −0.24 dioptres (standard deviation 0.30) in the conventional diffractive group, showing no statistically significant variation (P = 0.39). Overall refractive predictability proved virtually identical, with 83.5 percent of eyes implanted with the sinusoidal design and 84.7 percent of eyes receiving the diffractive design achieving final postoperative refractions within ±0.50 dioptres of the intended emmetropic target (P = 0.88). Furthermore, 100 percent of operated eyes across both treatment arms landed successfully within ±1.00 dioptre of target refraction, establishing that neither implant exhibited anomalous refractive shifts or unexpected axial instability over the 12-month observation period.

Defocus curve profiling demonstrated superior optical breadth across intermediate and near ranges for the sinusoidal design when tested under distance-corrected conditions from +1.00 to −4.00 dioptres. Trapezoidal area-under-the-curve metrics demonstrated significantly lower logMAR values across distance, intermediate (−1.00 to −2.00 dioptres), and near (−2.50 to −3.50 dioptres) zones for the sinusoidal lens (all P < 0.001). In secondary contrast sensitivity evaluations under photopic conditions without glare, the sinusoidal platform generated higher scores at 3, 6, and 12 cycles per degree (all P < 0.001), while performance at 18 cycles per degree showed no divergence between groups (P = 0.21). Under mesopic conditions with glare, unadjusted comparisons favoured the sinusoidal optic across all four spatial frequencies (all P ≤ 0.007). When controlling the false discovery rate across contrast comparisons, all seven initially significant advantages remained robust, though subsequent propensity-score adjustments revealed that the mesopic contrast benefit remained distinguishable from zero only at lower spatial frequencies of 3 and 6 cycles per degree.

Patient-reported functional questionnaires and dysphotopsia grading mirrored the trends observed during clinical testing, demonstrating improved subjective tolerance for the sinusoidal lens profile. The National Eye Institute Visual Function Questionnaire composite score reached 90.9 points (standard deviation 6.1) in the sinusoidal group versus 88.5 points (standard deviation 5.7) in the comparator cohort at 12 months (P < 0.001). On 0-to-10 severity scales, patients receiving the sinusoidal lens reported significantly lower scores for both halo and glare phenomena at 3 and 12 months, whereas night-driving difficulty ratings did not differ significantly between the groups. Complete intermediate spectacle independence favoured the sinusoidal lens substantially at 12 months, with 67.6 percent reporting zero spectacle use compared to 48.8 percent among diffractive lens recipients (P < 0.001). Distance spectacle independence was similar between arms, while complete near spectacle independence, which had initially favoured the sinusoidal lens at 3 months (29.4% vs. 18.2%; P = 0.02), converged to statistically indistinguishable levels by 12 months (35.9% vs. 32.9%; P = 0.65). Willingness to select the same intraocular lens reached 84.7 percent and 77.6 percent respectively, representing no statistically significant divergence (P = 0.13).

Safety outcomes documented through 12 months revealed low overall adverse event rates across both study cohorts. No patient in either cohort developed postoperative cystoid macular oedema. Elevated intraocular pressure spikes were noted in four eyes within the diffractive group and zero eyes in the sinusoidal group. Asymptomatic lens decentration occurred in two diffractive-lens eyes and zero sinusoidal-lens eyes; because these mild decentration events lacked visual significance and did not compromise optical metrics, both eyes remained within the analysis cohort as descriptive safety cases rather than protocol exclusions. Routine clinical slit-lamp inspections documented posterior capsule opacification, leading to Nd:YAG laser capsulotomy in 11 eyes (6.5 percent) within the sinusoidal cohort and 17 eyes (10.0 percent) within the diffractive cohort by 12 months, findings documented strictly as non-interpreted descriptive safety metrics.

To account for the non-randomized allocation and baseline disparities—including worse baseline visual acuity, lower mean keratometry, and fewer female participants in the sinusoidal group—the researchers conducted rigorous post-hoc propensity-score sensitivity analyses. Inverse-probability-of-treatment weighting across 17 baseline covariates successfully brought the maximum standardized mean difference down from 0.606 to 0.059 across an effective sample size of 256.6 eyes. Propensity-adjusted models estimated treatment differences of −0.027 logMAR for intermediate acuity (95% confidence interval −0.040 to −0.012) and −0.065 logMAR for near acuity (−0.078 to −0.053), closely replicating the initial multivariable findings. Doubly robust estimation, weight trimming, and restriction to the 314 eyes meeting strict common support yielded consistent intermediate estimates ranging from −0.023 to −0.027 logMAR and near estimates from −0.064 to −0.066 logMAR. Calculation of E-values yielded 2.57 for intermediate acuity and 5.36 for near acuity, demonstrating that an unmeasured confounding factor would require an association of at least 5.4 on the risk-ratio scale with both treatment assignment and near outcome to nullify the observed visual benefit.

Despite the statistical robustness of the primary findings, the authors emphasized essential clinical and methodological limitations inherent to retrospective non-randomized research. Individual rationales guiding surgical lens selection were not recorded in surgical logs, and unmeasured factors including procurement patterns, lens inventory shifts, and surgeon judgment could not be captured retrospectively. Crucially, preoperative lens-opacity grading and phacoemulsification ultrasound energy data were unavailable, preventing direct statistical adjustment for cataract density. Furthermore, complete-case cohort requirements excluded patients lost to 12-month follow-up, and subjective questionnaire scores may have reflected baseline visual expectations rather than purely physical optical advantages. Emphasizing that these clinical results reflect two specific proprietary lens designs rather than class-wide properties of trifocal implants, the investigators concluded that prospective, randomized clinical trials employing masked testing are required to definitively isolate sinusoidal optical architecture from unmeasured confounding.

Subject of Research: Comparative visual, refractive, and patient-reported outcomes of sinusoidal versus conventional diffractive trifocal intraocular lenses

Article Title: Visual, refractive and patient-reported outcomes after two trifocal intraocular lens designs: a 12-month comparative cohort study

Article References: Argon, B. D., & SoyyiÄŸit, E. (2026). Visual, refractive and patient-reported outcomes after two trifocal intraocular lens designs: a 12-month comparative cohort study. BMC Ophthalmology, 26(1), Article 663. https://doi.org/10.1186/s12886-026-05426-z

Image Credits: AI Generated

DOI: 10.1186/s12886-026-05426-z

Keywords: trifocal intraocular lenses, cataract surgery, presbyopia correction, AcrivaUD Trinova Pro C, Omni Trioptix Trifocal, uncorrected intermediate visual acuity, uncorrected near visual acuity, defocus curves, contrast sensitivity, dysphotopsia, spectacle independence, NEI VFQ-25, refractive predictability, propensity score weighting, ophthalmology, monocular defocus testing, mesopic contrast sensitivity

News Source: Ophelia Keating. (November 11, 2026). Sinusoidal Trifocal Intraocular Lenses Improve Intermediate and Near Visual Acuity. Scienmag.

Tags: AcrivaUD Trinova Pro Ccataract surgerycontrast sensitivitydefocus curvesdysphotopsiamesopic contrast sensitivitymonocular defocus testingNEI VFQ-25Omni Trioptix TrifocalOphthalmologypresbyopia correctionpropensity score weightingrefractive predictabilityspectacle independencetrifocal intraocular lensesuncorrected intermediate visual acuityuncorrected near visual acuity
Share12Tweet7Share2ShareShareShare1

Related Posts

Repeated COVID-19 Boosters Preserve Long-Term Memory B Cells in Vulnerable Nursing Home Residents

Repeated COVID-19 Boosters Preserve Long-Term Memory B Cells in Vulnerable Nursing Home Residents

November 19, 2026
Uzbekistan Study Links Household Hygiene Sharing to Hepatitis D Infection

Uzbekistan Study Links Household Hygiene Sharing to Hepatitis D Infection

November 19, 2026

Chronic Jet Lag Disrupts Molecular Brain Clocks and Kynurenine Metabolism in Rats

November 19, 2026

Single-Dose PCV20 Vaccination Proves Cost-Effective for Vulnerable Adults in India

November 19, 2026

POPULAR NEWS

  • Engineered CAR Natural Killer Cells Target Mesothelin in Ovarian Cancer Models

    Engineered CAR Natural Killer Cells Target Mesothelin in Ovarian Cancer Models

    29 shares
    Share 12 Tweet 7
  • Industrial Winemaking Enzyme Cocktail Enables High Efficiency Genetic Transformation in Medicinal Mushrooms

    29 shares
    Share 12 Tweet 7
  • Infantile Case Report Links Novel NAXE Gene Variant to Fatal Encephalopathy

    29 shares
    Share 12 Tweet 7
  • Inherited Genetic Variants Significantly Shape Glioma Risk and Tumor Biology

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

New Open-Source App Mycol Accelerates Biological Image Analysis and Quantification

Repeated COVID-19 Boosters Preserve Long-Term Memory B Cells in Vulnerable Nursing Home Residents

Uzbekistan Study Links Household Hygiene Sharing to Hepatitis D Infection

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.